Cambridge, MA, United States of America

Dhrubajyoti Datta

This inventor holds 1 USPTO granted patent and 12 published patent applications. Top assignee: Alnylam Pharmaceuticals, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dhrubajyoti Datta. Retrieved from https://idiyas.com/inventor/dhrubajyoti-datta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dhrubajyoti Datta: Innovator in Modified Oligonucleotides

Introduction

Dhrubajyoti Datta is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of modified oligonucleotides. His innovative work has led to advancements in therapeutic applications.

Latest Patents

Dhrubajyoti Datta holds 1 patent for his invention related to modified oligonucleotides. This patent showcases his expertise and commitment to enhancing biopharmaceutical technologies.

Career Highlights

Currently, Dhrubajyoti Datta is employed at Alnylam Pharmaceuticals, Inc. His role at this leading biopharmaceutical company allows him to work on cutting-edge research and development projects that aim to improve patient outcomes.

Collaborations

Throughout his career, Dhrubajyoti has collaborated with esteemed colleagues, including Pawan Kumar and Muthiah Manoharan. These partnerships have fostered a collaborative environment that encourages innovation and scientific discovery.

Conclusion

Dhrubajyoti Datta is a prominent figure in the field of biotechnology, with a focus on modified oligonucleotides. His contributions and collaborations continue to drive advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…